SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-004368
Filing Date
2023-02-13
Accepted
2023-02-13 06:05:26
Documents
17
Period of Report
2023-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50975
2 ex1-1.htm EX-1.1 557345
3 ex4-2.htm EX-4.2 127914
4 ex4-3.htm EX-4.3 120323
5 ex4-4.htm EX-4.4 140078
6 ex99-1.htm EX-99.1 13282
  Complete submission text file 0001493152-23-004368.txt   1401240

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sonn-20230208.xsd EX-101.SCH 3230
8 XBRL LABEL FILE sonn-20230208_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE sonn-20230208_pre.xml EX-101.PRE 22361
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3626
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 23614437
SIC: 2834 Pharmaceutical Preparations